OFFICIAL STOCK MARKET AND ECONOMY THREAD VOL. A NEW CHAPTER

[shibadekobe]

AMC to Issue Class A Stock in Exchange for Subordinated Notes

AMC Entertainment Holdings entered into privately negotiated exchange agreements and said it will issue 23.3m shares of Class A common stock in exchange for $163.9m aggregate principal amount of its 10%/12% Cash/PIK Toggle Second Lien Subordinated Notes due 2026.

news.bloomberglaw.com

 

[WASHED KING]

And thats why I sold yesterday.

Can't stand AMC's CEO, he's the reason I don't have a lambo now.

 

[biggie62]

And thats why I sold yesterday.

Can't stand AMC's CEO, he's the reason I don't have a lambo now.

Buying a lambo is the easy part. Now maintaining it, that’s the expensive part.

 

[Arthur Shelby]

 

[shibadekobe]

 

[OprahsBabyDaddy6]

Bruh…. where can I find info to be privy ahead of the game on pumps like this one?

 

[shibadekobe]

Bruh…. where can I find info to be privy ahead of the game on pumps like this one?

they loaded dip on Friday and running again in pre

 

[noskey]

Stock up 28% today. My $7/share buy has aged wonderfully. Should have bought more when their CEO rightfully stood up for Palestine.

 

[ballinsam23]

I would short the **** out of that

Online pharmacies that compound these popular meds are being cracked down on big time.

 

[noskey]

I would short the **** out of that

Online pharmacies that compound these popular meds are being cracked down on big time.

I'm weighing up the idea of puts to protect the downside, but I dont think we're close to being done with the long-term growth. Short term? Yeah volatility is normal and expected.

 

[ballinsam23]

I'm weighing up the idea of puts to protect the downside, but I dont think we're close to being done with the long-term growth. Short term? Yeah volatility is normal and expected.

During the whole Ozempic craze, the reason pharmacies started compounding was because it was significantly cheaper for the pharmacy and you never had to worry about backorders/out of stocks for the patient.

The actual meds are widely available now and pretty much every insurance covers it.

They're about 1-2 years late to the game.

 

[noskey]

During the whole Ozempic craze, the reason pharmacies started compounding was because it was significantly cheaper for the pharmacy and you never had to worry about backorders/out of stocks for the patient.

The actual meds are widely available now and pretty much every insurance covers it.

They're about 1-2 years late to the game.

Late, or introducing something to their user base who hasn't attempted to obtain these products yet, at a price thats higher than a copay but low enough that people will buy it?

Until HIMS shows us that their growth is slowing, I'm riding it.

 

[ballinsam23]

Late, or introducing something to their user base who hasn't attempted to obtain these products yet, at a price thats higher than a copay but low enough that people will buy it?

Until HIMS shows us that their growth is slowing, I'm riding it.

Been in pharmaceuticals for 7+ years now. Everyone got out of compounding Ozempic. From a business standpoint and clinical standpoint (compounded versions have higher adverse effects).

Hope it works out for you. Good luck.

 

[xbiker47]

NVDA earnings this week

 

[noskey]

Been in pharmaceuticals for 7+ years now. Everyone got out of compounding Ozempic. From a business standpoint and clinical standpoint (compounded versions have higher adverse effects).

Hope it works out for you. Good luck.

Oh I don't doubt you and your words aren't falling on deaf ears. But what downside is there other than "everyone is doing it"? HIMS doesn't succeed cause they're doing anything different, it's cause their marketing drove their user base to grow like crazy. As long as they have a strong and loyal user base and the TAM isn't decreasing, I just don't see a reason to ditch em (long term). Wegovy knockoff, or not, they seem primed to win the Healthcare app wars.

 

[shibadekobe]

https://www.cnbc.com/2024/05/22/nvidia-announces-10-for-1-stock-split.html

NVDA Adjusted gross margin 78.9%, estimate 77%
NVIDIA SEES 2Q REV. $28.0B PLUS OR MINUS 2%, EST. $26.8B
NVIDIA 1Q REV. $26.0B, EST. $24.69B

 

[degenerate423]

150% dividend increase as well .

 

[johnnyredstorm]

Compound ozempic can apparently be dangerous

It’s a good narrative for HIMS but something I’d trade the hype on

 

[superantigen]

Excluding China's invasion of Taiwan, what's the bear case for NVDA? Also, it seems like NVDA is so far ahead of the game in designing the chips that power LLM that the threat of other Big Tech players designing their own AI chips and taking market share cannot be a legitimate bear case.

...

 

[degenerate423]

Excluding China's invasion of Taiwan, what's the bear case for NVDA? Also, it seems like NVDA is so far ahead of the game in designing the chips that power LLM that the threat of other Big Tech players designing their own AI chips and taking market share cannot be a legitimate bear case.

...

I don’t see a bear case right now either that doesn’t involve a war or Jensen deciding to leave the company. You plan on grabbing some shares before the split?

 

[superantigen]

I don’t see a bear case right now either that doesn’t involve a war or Jensen deciding to leave the company. You plan on grabbing some shares before the split?

Actually grabbed a share yesterday because I had a feeling they'd announce a split.

Also got tired of sitting on the sideline and missing out on gains, especially after I stupidly sold my entire NVDA position back in '23 before the epic run up. Figured now would be as good of a time as any to rebuild my position. I'll be nibbling here and there moving forward.


...

 

[xbiker47]

Is the split really gonna bring in that many more retail investors pushing the stock in the short term?

 

[shibadekobe]

 

[ballinsam23]

Is the split really gonna bring in that many more retail investors pushing the stock in the short term?

I think so. Sentiment for newer retail traders is obviously "1,000 is too high of a price"

Psychologically a split to $100 will grab those investors

 

[johnnyredstorm]

NVDA’s growth will slowdown in a couple of years as competitors ramp up their own products but it’s still a leader in this space with a tremendous opportunity in front of it. I got shaken out of my position during the bear market and never got back in. Would maybe trim some shares, but keep a core forever.